Africa (WHO region) vs Belize: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Africa (WHO region)
89.0%
in 2014
Belize
100.0%
in 2014
Africa (WHO region) rank
2nd
Belize rank
1st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Africa (WHO region)
- Belize
How they compare
Belize currently reports 100.0% against 89.0% in Africa (WHO region), a difference of 11.0%.
That makes Belize's figure about 1.1 times Africa (WHO region)'s.
The two have swapped places 5 times across 11 shared years of data; in 2003 it was Africa (WHO region) ahead.
Africa (WHO region) ranks 2nd and Belize ranks 1st of 11 groups.
Across the 2 decades both report, Africa (WHO region) averaged higher in 1 and Belize in 1.
Head to head by decade
| Decade | Africa (WHO region) | Belize | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.7% | 73.4% | 8.3% | Africa (WHO region) |
| 2010s | 85.8% | 96.0% | 10.2% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Africa (WHO region) or Belize?
- Belize, at 100.0% against 89.0% in Africa (WHO region) as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Africa (WHO region) and Belize?
- 11.0%, with Belize ahead.
- How many years of comparable data are there for Africa (WHO region) and Belize?
- 11 years are reported by both, from 2003 to 2014.
- How do Africa (WHO region) and Belize rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Africa (WHO region) ranks 2nd and Belize ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.